Skip to contentV
Vycor Medical Inc
V
VYCOVycor Medical Inc Q4 2020 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$291.62K$291.62Kderived−5.1% vs Q4 2019 Net Income-$200.36K-$200.36KderivedN/M vs Q4 2019 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$238,279−24.3% Operating Incomederived-$165,274N/M Operating Cash Flowderived-$5,929N/M Free Cash Flowderived-$7,849N/M Margins · derivedGross margin81.7%−20.7 pt vs Q4 2019
Operating margin-56.7%+9.5 pt vs Q4 2019
Net margin-68.7%+3.2 pt vs Q4 2019
ended Dec 31, 2020 · filed Mar 31, 2021 · 90 d after period end